Page last updated: 2024-10-21

2-amino-5-phosphonovalerate and Cranial Nerve X Injury

2-amino-5-phosphonovalerate has been researched along with Cranial Nerve X Injury in 1 studies

2-Amino-5-phosphonovalerate: The D-enantiomer is a potent and specific antagonist of NMDA glutamate receptors (RECEPTORS, N-METHYL-D-ASPARTATE). The L form is inactive at NMDA receptors but may affect the AP4 (2-amino-4-phosphonobutyrate; APB) excitatory amino acid receptors.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Steenland, HW1
Liu, H1
Sood, S1
Liu, X1
Horner, RL1

Other Studies

1 other study available for 2-amino-5-phosphonovalerate and Cranial Nerve X Injury

ArticleYear
Respiratory activation of the genioglossus muscle involves both non-NMDA and NMDA glutamate receptors at the hypoglossal motor nucleus in vivo.
    Neuroscience, 2006, Volume: 138, Issue:4

    Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Excitatory Amino Acid An

2006